Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334–482. https://doi.org/10.1161/CIR.0000000000001106.
Philippe Unger M-AC. Mixed aortic valve disease: A diagnostic Challenge, a prognostic threat. Struct HEART. 2020;4:468–74. https://doi.org/10.1080/24748706.2020.1817643.
Honda S, Kitai T, Okada Y, Tani T, Kim K, Kaji S, et al. Impact of aortic regurgitation on the prognosisof severe aortic stenosis. Heart. 2012;98(21):1591–4. https://doi.org/10.1136/heartjnl-2012-302089.
Egbe AC, Luis SA, Padang R, Warnes CA. Outcomes in moderate mixed aortic valve disease: is it time for a paradigm shift? J Am Coll Cardiol. 2016;24(20):2321–9. https://doi.org/10.1016/j.jacc.2016.03.509.
Egbe AC, Khan AR, Boler A, Said SM, Geske JB, Miranda WR, Akintoye E, Connolly HM, Warnes CA, Oh JK. (2018) Role of diastolic function indices in the risk stratification of patients with mixed aortic valve disease. Eur Heart J Cardiovasc Imaging 1;19(6):668–674. https://doi.org/10.1093/ehjci/jex148
Huang L, Lai X, Xu L, Zeng Z, Xia H. Left ventricular reverse remodeling after transcatheter aortic valve replacement for predominant aortic stenosis and mixed aortic valve disease. J Clin Ultrasound. 2023;51(9):1453–60. https://doi.org/10.1002/jcu.23585.
Koga-Ikuta A, Fukushima S, Kawamoto N, Saito T, Shimahara Y, Yajima S, et al. Reverse remodelling after aortic valve replacement for chronic aortic regurgitation. Interact Cardiovasc Thorac Surg. 2021(1). https://doi.org/10.1093/icvts/ivab046.
Sousa Nunes F, Amaral Marques C, Isabel Pinho A, Sousa-Pinto B, Beco A, Ricardo Silva J, Saraiva F, Macedo F, Leite-Moreira A, Sousa C. Reverse left ventricular remodeling after aortic valve replacement for aortic stenosis: a systematic review and meta-analysis. Front Cardiovasc Med. 2024;4:11:1407566. https://doi.org/10.3389/fcvm.2024.1471225.
Saijo Y, Kusunose K, Takahashi T, Yamada H, Sata M, Sato K, et al. Impact of transcatheter aortic valve replacement on cardiac reverse remodeling and prognosis in mixed aortic valve disease. J Am Heart Assoc. 2024;20(4):e033289. https://doi.org/10.1161/JAHA.123.033289.
Sato K, Seo Y, Ishizu T, Albakaa NK, Izumo M, Okada A, et al. Cardiac reversibility and survival after transcatheter aortic valve implantation in patients with low-gradient aortic stenosis. J Am Heart Assoc. 2023;15(16):e029717. https://doi.org/10.1161/JAHA.123.029717.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1-e3914. https://doi.org/10.1016/j.echo.2014.10.003.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M, American Society of Echocardiography; European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2023;36(4):445. https://doi.org/10.1016/j.echo.2023.02.005.
Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension. 1987;9(2 Pt 2):II19-26. https://doi.org/10.1161/01.hyp.9.2_pt_2.ii19.
Article PubMed CAS Google Scholar
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American college of Cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;9(10):e784. https://doi.org/10.1161/CIR.0000000000000966.
Dismorr M, Glaser N, Franco-Cereceda A, Sartipy U. Effect of prosthesis-patient mismatch on long-term clinical outcomes after bioprosthetic aortic valve replacement. J Am Coll Cardiol. 2023;14(10):964–75. https://doi.org/10.1016/j.jacc.2022.12.023.
Grossman W, Paulus WJ. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. J Clin Invest. 2013;123(9):3701–3. https://doi.org/10.1172/JCI69830.
Article PubMed PubMed Central CAS Google Scholar
Vollema EM, Singh GK, Prihadi EA, Regeer MV, Ewe SH, Ng ACT, et al. Time course of left ventricular remodelling and mechanics after aortic valve surgery: aortic stenosis vs. aortic regurgitation. Eur Heart J Cardiovasc Imaging. 2019;1(10):1105–11. https://doi.org/10.1093/ehjci/jez049.
Izumi C, Kitai T, Kume T, Onishi T, Yuda S, Hirata K, Yamashita E, Kawata T, Nishimura K, Takeuchi M, Nakatani S. (2019) Effect of Left Ventricular Reverse Remodeling on Long-term Outcomes After Aortic Valve Replacement. Am J Cardiol. 1;124(1):105–112. https://doi.org/10.1016/j.amjcard.2019.04.010
Wilde NG, Mauri V, Piayda K, Al-Kassou B, Shamekhi J, Maier O, et al. Left ventricular reverse remodeling after transcatheter aortic valve implantation in patients with low-flow low-gradient aortic stenosis. Hellenic J Cardiol. 2023;74:1–7. https://doi.org/10.1016/j.hjc.2023.04.009.
Saijo Y, Isaza N, Conic JZ, Desai MY, Johnston D, Roselli EE, et al. Left ventricular longitudinal strain in characterization and outcome assessment of mixed aortic valve disease phenotypes. JACC Cardiovasc Imaging. 2021;14(7):1324–34. https://doi.org/10.1016/j.jcmg.2021.01.020.
Sá MP, Jacquemyn X, Van den Eynde J, Tasoudis P, Dokollari A, Torregrossa G, et al. Impact of prosthesis-patient mismatch after transcatheter aortic valve replacement: meta-analysis of Kaplan-Meier-derived individual patient data. JACC Cardiovasc Imaging. 2023;16(3):298–310. https://doi.org/10.1016/j.jcmg.2022.07.013.
Isaza N, Desai MY, Kapadia SR, Krishnaswamy A, Rodriguez LL, Grimm RA, et al. Long-term outcomes in patients with mixed aortic valve disease and preserved left ventricular ejection fraction. J Am Heart Assoc. 2020;7:e014591. https://doi.org/10.1161/JAHA.119.014591.
Chambers J. The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors. Heart. 2006;92(3):420–3. https://doi.org/10.1136/hrt.2005.074112.
Comments (0)